ROCKVILLE, Md. and SHANGHAI, Sept. 5,
2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the
"Company"), is a global biotechnology company focused on bringing
highly differentiated medicines to patients around the world
through the discovery, development, and commercialization of novel
immunotherapies and biologics for oncology, today announced its
participation in the following conferences in September 2023.
Details of the conferences and management presentation are as
follows:
H.C. Wainwright 25th Annual Global Investment
Conference (Hybrid)
Presentation: Monday, September 11th at
11:30 a.m. E.S.T
Presenter: Mr. Raj Kannan, CEO
One-on-one and small group meetings: Sept 11-13, 2023
Management participants: Mr. Raj Kannan, CEO; Dr. John Hayslip, CMO; Dr. Andrew Zhu,
President and Head of R&D; and Mr. Tyler Ehler, Senior
Director, Investor Relations
For more information, please contact your H.C. Wainwright
representative.
2023 Cantor Global Healthcare Conference (In Person)
Presentation: Thursday, September 28th at
2:25 p.m. E.S.T.
Presenter: Mr. Raj Kannan, CEO; and Dr. John Hayslip, CMO
One-on-one and small group meetings: Sept 26-28, 2023
Management participants: Mr. Raj Kannan, CEO; Dr. John Hayslip, CMO; and Mr. Tyler Ehler,
Senior Director, Investor Relations
For more information, please contact your Cantor
representative.
About I-Mab
I-Mab (Nasdaq: IMAB) is a global biotechnology
company focused on bringing highly differentiated medicines to
patients around the world through the discovery, development, and
commercialization of novel immunotherapies and biologics for
oncology. I-Mab's innovative pipeline is driven by
internal R&D's Fast-to-Proof-of-Concept, Fast-to-Market
development strategies, and through global partnerships. For
more information, please
visit https://www.i-mabbiopharma.com and follow us
on LinkedIn, Twitter, and WeChat.
I-Mab Contacts
Investors
|
Media
|
Tyler Ehler
|
Gigi Feng
|
Senior Director,
Investor Relations
|
Chief Communications
Officer
|
IR@i-mabbiopharma.com
|
PR@i-mabbiopharma.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/i-mab-announces-upcoming-participation-at-september-conferences-301917513.html
SOURCE I-Mab